Asia Pacific Cell Therapy Market Size & Forecast Report, 2028
Asia Pacific Cell Therapy Industry Overview The Asia Pacific cell therapy market size is expected to reach USD 2.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 14.9% from 2021 to 2028. Rapid advancements in regenerative medicine are anticipated to provide effective solutions for chronic conditions. A substantial number of companies in the growing markets, such as India and South Korea, are striving to capitalize on the untapped opportunities in the market, thereby driving the market. Asia Pacific Cell Therapy Market Segmentation Grand View Research has segmented the Asia Pacific cell therapy market on the basis of use-type, therapy type, and country: Based on the Use-type Insights, the market is segmented into Clinical-use and Research-use. The research-use segment dominated the market and accounted for the largest revenue share of 87.0% from 2021 to 2028. Currently, stem and non-stem c...